Limits...
Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases.

Rosolova H, Nussbaumerova B - EPMA J (2011)

Bottom Line: Although major progress has been made in the management of the classical modifiable cardiovascular risk factors, unhealthy lifestyle conduces to an increasing prevalence of overweight, obesity, metabolic disorders, type 2 diabetes mellitus, premature atherosclerosis and cardiovascular diseases.Up-to-date primary preventive strategies according to the European Guidelines, especially the high risk strategy approach, are being implemented.Cardio-metabolic biomarkers, especially high sensitivity C-reactive protein, albuminuria, N-terminal pro-brain natriuretic peptide, and imaging procedures (carotid intima-media thickness measured by ultrasound) could improve the prediction of cardiovascular diseases and type 2 diabetes beyond that using traditional risk factors.

View Article: PubMed Central - PubMed

Affiliation: Centre of Preventive Cardiology of the 2nd Medical Department University Hospital, E. Benese 13, 305 99 Pilsen, Czech Republic.

ABSTRACT
Cardiovascular atherosclerotic diseases represent the main cause of death in the developed and developing populations. Although major progress has been made in the management of the classical modifiable cardiovascular risk factors, unhealthy lifestyle conduces to an increasing prevalence of overweight, obesity, metabolic disorders, type 2 diabetes mellitus, premature atherosclerosis and cardiovascular diseases. That is why cardio-metabolic risk prediction should be superior in the primary prevention of atherosclerosis and cardiovascular diseases. Up-to-date primary preventive strategies according to the European Guidelines, especially the high risk strategy approach, are being implemented. Individual cardiovascular and better cardio-metabolic risk assessment represents the basic approach in the individualized primary prevention of cardiovascular diseases and type 2 diabetes mellitus. Cardio-metabolic biomarkers, especially high sensitivity C-reactive protein, albuminuria, N-terminal pro-brain natriuretic peptide, and imaging procedures (carotid intima-media thickness measured by ultrasound) could improve the prediction of cardiovascular diseases and type 2 diabetes beyond that using traditional risk factors.

No MeSH data available.


Related in: MedlinePlus

Mortality of ischemic heart disease in European and other countries [2]. CARK - 5 central Asian republics including Kazakhstan, CIS - 12 countries of the “Commonwealth of Independent States”, EU – European Union, Eur-A – Western European countries, Eur – B+C – Middle and Eastern European countries
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3405365&req=5

Fig1: Mortality of ischemic heart disease in European and other countries [2]. CARK - 5 central Asian republics including Kazakhstan, CIS - 12 countries of the “Commonwealth of Independent States”, EU – European Union, Eur-A – Western European countries, Eur – B+C – Middle and Eastern European countries

Mentions: Despite the decreasing rates of cardiovascular mortality in West European countries at the end of the 20th century, but in Poland and Czech Republic from the East European countries only, CVD have been the most common cause of mortality during the last 50 years. More than half of the European populations die from CVD, mostly from ischemic heart disease (Fig. 1) [2]. That is why many activities of the European Society of Cardiology and, consequently, national societies of Cardiology are focused on preventive approaches to the most common cause of death, i.e., CVD. It was particularly the European Association for Cardiovascular Prevention and Rehabilitation (EACPR) [formerly the Working Group on Epidemiology and Prevention of Cardiovascular Diseases of the European Society of Cardiology], has consistently addressed this issue and developed the Joint Task Force Recommendations on CVD Prevention in cooperation with other medical societies regularly at a 4-year interval since 1994 [3].Fig. 1


Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases.

Rosolova H, Nussbaumerova B - EPMA J (2011)

Mortality of ischemic heart disease in European and other countries [2]. CARK - 5 central Asian republics including Kazakhstan, CIS - 12 countries of the “Commonwealth of Independent States”, EU – European Union, Eur-A – Western European countries, Eur – B+C – Middle and Eastern European countries
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3405365&req=5

Fig1: Mortality of ischemic heart disease in European and other countries [2]. CARK - 5 central Asian republics including Kazakhstan, CIS - 12 countries of the “Commonwealth of Independent States”, EU – European Union, Eur-A – Western European countries, Eur – B+C – Middle and Eastern European countries
Mentions: Despite the decreasing rates of cardiovascular mortality in West European countries at the end of the 20th century, but in Poland and Czech Republic from the East European countries only, CVD have been the most common cause of mortality during the last 50 years. More than half of the European populations die from CVD, mostly from ischemic heart disease (Fig. 1) [2]. That is why many activities of the European Society of Cardiology and, consequently, national societies of Cardiology are focused on preventive approaches to the most common cause of death, i.e., CVD. It was particularly the European Association for Cardiovascular Prevention and Rehabilitation (EACPR) [formerly the Working Group on Epidemiology and Prevention of Cardiovascular Diseases of the European Society of Cardiology], has consistently addressed this issue and developed the Joint Task Force Recommendations on CVD Prevention in cooperation with other medical societies regularly at a 4-year interval since 1994 [3].Fig. 1

Bottom Line: Although major progress has been made in the management of the classical modifiable cardiovascular risk factors, unhealthy lifestyle conduces to an increasing prevalence of overweight, obesity, metabolic disorders, type 2 diabetes mellitus, premature atherosclerosis and cardiovascular diseases.Up-to-date primary preventive strategies according to the European Guidelines, especially the high risk strategy approach, are being implemented.Cardio-metabolic biomarkers, especially high sensitivity C-reactive protein, albuminuria, N-terminal pro-brain natriuretic peptide, and imaging procedures (carotid intima-media thickness measured by ultrasound) could improve the prediction of cardiovascular diseases and type 2 diabetes beyond that using traditional risk factors.

View Article: PubMed Central - PubMed

Affiliation: Centre of Preventive Cardiology of the 2nd Medical Department University Hospital, E. Benese 13, 305 99 Pilsen, Czech Republic.

ABSTRACT
Cardiovascular atherosclerotic diseases represent the main cause of death in the developed and developing populations. Although major progress has been made in the management of the classical modifiable cardiovascular risk factors, unhealthy lifestyle conduces to an increasing prevalence of overweight, obesity, metabolic disorders, type 2 diabetes mellitus, premature atherosclerosis and cardiovascular diseases. That is why cardio-metabolic risk prediction should be superior in the primary prevention of atherosclerosis and cardiovascular diseases. Up-to-date primary preventive strategies according to the European Guidelines, especially the high risk strategy approach, are being implemented. Individual cardiovascular and better cardio-metabolic risk assessment represents the basic approach in the individualized primary prevention of cardiovascular diseases and type 2 diabetes mellitus. Cardio-metabolic biomarkers, especially high sensitivity C-reactive protein, albuminuria, N-terminal pro-brain natriuretic peptide, and imaging procedures (carotid intima-media thickness measured by ultrasound) could improve the prediction of cardiovascular diseases and type 2 diabetes beyond that using traditional risk factors.

No MeSH data available.


Related in: MedlinePlus